Bausch Health is acquiring DURECT primarily for its lead asset, called larsucosterol. This novel therapeutic molecule is an ...

Sitryx regains rights to SYX-1042 itaconate mimetic for chronic autoimmune and inflammatory diseases from Lilly following ...

In his regular browsing on AliExpress, [Ben Jeffrey] came across something he didn’t understand—a $5 fiber optic to RF cable TV adapter. It was excessively cheap, and even more mysteriously, ...

Watching a sci-fi TV show doesn't mean always mean you're dabbling in fantasy - they can be actual windows to the future.

Assembly Biosciences, Inc.'s ABI-5366 showed strong interim phase 1b results in HSV-2 recurrent genital herpes patients.

From A-list celebrities to the people in our own lives, breast cancer can can truly happen to anyone — and the stats show it.

In December 2024, Dewpoint Therapeutics CEO Ameet Nathwani said the biotech’s cash runway would last until the third quarter of 2025.

GAAP net loss per share was $(11.29) for Q2 2025, missing the consensus GAAP EPS estimate of $(4.62) by a wide margin, mainly due to a $17.0 million up-front license fee. NextCure advanced both its ...

Ptc Therapeutics(NASDAQ:PTCT), a biopharmaceutical company specializing in therapies for rare diseases, released its second quarter 2025 earnings on August 7, 2025. The main headline was a beat on ...

Lithium-Ion Battery Energy Storage System Lithium-ion Battery Energy Storage System Market was valued at $4.5 Bn in 2021, is projected to r ...

Discover how inflammation peptides are revolutionising our understanding of immune regulation, offering new avenues for ...

Winspace OrangeSeal has confirmed that rider Aurela Nerlo tested positive for the banned substance LGD-4033 during the Tour ...